Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
AstraZeneca
Scott D Solomon; John J V McMurray; Brian Claggett; Rudolf A de Boer; David DeMets; Adrian F Hernandez; Silvio E Inzucchi; Mikhail N Kosiborod; Carolyn S P Lam; Felipe Martinez; Sanjiv J Shah; Akshay S Desai; Pardeep S Jhund; Jan Belohlavek; Chern-En Chiang; C Jan Willem Borleffs; Josep Comin-Colet; Dan Dobreanu; Jaroslaw Drozdz; James C Fang; Marco Antonio Alcocer-Gamba; Waleed Al Habeeb; Yaling Han; Jose Walter Cabrera Honorio; Stefan P Janssens; Tzvetana Katova; Masafumi Kitakaze; Béla Merkely; Eileen O'Meara; Jose Francisco Kerr Saraiva; Sergey N Tereshchenko; Jorge Thierer; Muthiah Vaduganathan; Orly Vardeny; Subodh Verma; Vinh Nguyen Pham; Ulrica Wilderäng; Natalia Zaozerska; Erasmus Bachus; Daniel Lindholm; Magnus Petersson; Anna Maria Langkilde; DELIVER Trial Committees and Investigators